Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinaciguat in Acute Decompensated Heart Failure (COMPOSE EARLY)
NCT01064037Phase 2Terminated
- Sponsor
- Bayer
- Start
- Apr 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 2 trial of cinaciguat in heart failure (HF), sponsored by Bayer. Started Apr 2010; status: terminated.
02
Drugs
cinaciguat
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01064037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01064037.